Evidence map›Paper›PMID 38177619›Full record

ArticleEuropean radiology2024

Interval cancer in the Córdoba Breast Tomosynthesis Screening Trial (CBTST): comparison of digital breast tomosynthesis plus digital mammography to digital mammography alone.

Cristina Pulido-Carmona, Sara Romero-Martín, José Luis Raya-Povedano, María Cara-García, Pilar Font-Ugalde, Esperanza Elías-Cabot, Margarita Pedrosa-Garriguet, Marina Álvarez-Benito

Open access · hybridAbstract readComparative Study
In one paragraph

Article in European radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Cristina Pulido-CarmonaMaimónides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain. kris_fn@hotmail.com.ORCID http://orcid.org/0000-0002-7864-6974
Sara Romero-MartínMaimónides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.
José Luis Raya-PovedanoMaimónides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.
María Cara-GarcíaMaimónides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.
Pilar Font-UgaldeMaimónides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.
Esperanza Elías-CabotMaimónides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.
Margarita Pedrosa-GarriguetMaimónides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.
Marina Álvarez-BenitoMaimónides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.
Instituto Maimónides de Investigación Biomédica de Córdoba · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis work aims to compare the interval cancer rate and interval cancer characteristics between women screened with digital breast tomosynthesis (DBT) + digital mammography (DM) and those screened with DM alone.

methodsThe interval cancer rate and interval cancer characteristics of the study population included in the Córdoba Breast Tomosynthesis Screening Trial (CBTST) were compared to a contemporary control population screened with DM. The tumour characteristics of screen-detected and interval cancers were also compared. Contingency tables were used to compare interval cancer rates. The chi-square test and Fisher's exact test were used to compare the qualitative characteristics of the cancers whereas Student's t test and the Mann-Whitney U test were used to analyse quantitative features.

resultsA total of 16,068 screening exams with DBT + DM were conducted within the CBTST (mean age 57.59 ± 5.9 [SD]) between January 2015 and December 2016 (study population). In parallel, 23,787 women (mean age 58.89 ± 5.9 standard deviation [SD]) were screened with DM (control population). The interval cancer rate was lower in the study population than in the control population (15 [0.93‰; 95% confidence interval (CI): 0.73, 1.14] vs 43 [1.8‰; 95% CI: 1.58, 2.04] respectively; p = 0.045). The difference in rate was more marked in women with dense breasts (0.95‰ in the study population vs 3.17‰ in the control population; p = 0.031). Interval cancers were smaller in the study population than in the control population (p = 0.031).

conclusionsThe interval cancer rate was lower in women screened with DBT + DM compared to those screened with DM alone. These differences were more pronounced in women with dense breasts. CLINICAL RELEVANCE STATEMENT: Women screened using tomosynthesis and digital mammography had a lower rate of interval cancer than women screened with digital mammography, with the greatest difference in the interval cancer rate observed in women with dense breasts. KEY POINTS: • The interval cancer rate was lower in the study population (digital breast tomosynthesis [DBT] + digital mammography [DM]) than in the control population (DM). • The difference in interval cancer rates was more pronounced in women with dense breasts. • Interval cancers were smaller in the study population (DBT + DM) than in the control population (DM).

Indexed as

Breast NeoplasmsEarly Detection of CancerMammographyAgedBreastFemaleHumansMass ScreeningMiddle AgedBreast neoplasmsDigital breast tomosynthesisMammographyMass screening

Identifiers

PMID38177619
PMCPMC11255077
OpenAlexW4390578184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.